We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Solutions Company Expands Quality Control Offering

By LabMedica International staff writers
Posted on 29 Jun 2010
A new range of lyophilised quality controls ensures longer shelf life and stability, resulting in greater continuity of lot supply. Other advantages of the new quality controls include more convenient storage at 2 °C - 8 °C and easier transportation.

The quality control sera are manufactured by Randox Laboratories (Crumlin, UK). Quality control guarantees good performance and ensures that results are of high quality and reliability. The company's Acusera range of quality controls currently covers over 290 parameters and is set to expand with the introduction of several new quality controls.

The new quality controls include coagulation, maternal screening, clinical chemistry, immunoassays, tumor markers, HbA1c, and thalassemia. Randox quality controls are true third party controls in that they are not designed or optimized for use with a specific manufacturer's instrument, calibrator, or reagent.

In addition to the extensive range of quality control materials Randox provides 24/7 an internet driven peer-group reporting system and RIQAS, an external quality assurance scheme providing customers with 15 external quality assessment (EQA) programs.

Randox develops, manufactures, and markets clinical diagnostic products including the Biochip Array Technology, clinical chemistry analyzers and reagents, quality controls, and EQA, as well as a complete life science range.

Related Links:
Randox Laboratories


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
29 Jun 2010  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
29 Jun 2010  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
29 Jun 2010  |   Clinical Chem.